AU582757B2 - A gangliosides mixture, useful as a therapeutical tool for eliminating painful effects of peripheral neuropathies - Google Patents

A gangliosides mixture, useful as a therapeutical tool for eliminating painful effects of peripheral neuropathies

Info

Publication number
AU582757B2
AU582757B2 AU44207/85A AU4420785A AU582757B2 AU 582757 B2 AU582757 B2 AU 582757B2 AU 44207/85 A AU44207/85 A AU 44207/85A AU 4420785 A AU4420785 A AU 4420785A AU 582757 B2 AU582757 B2 AU 582757B2
Authority
AU
Australia
Prior art keywords
mixture
gangliosides
useful
sub
peripheral neuropathies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU44207/85A
Other languages
English (en)
Other versions
AU4420785A (en
Inventor
Silvana Lorenzi
Aurelio Romeo
Francesco Della Valle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Publication of AU4420785A publication Critical patent/AU4420785A/en
Application granted granted Critical
Publication of AU582757B2 publication Critical patent/AU582757B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU44207/85A 1984-07-03 1985-06-26 A gangliosides mixture, useful as a therapeutical tool for eliminating painful effects of peripheral neuropathies Ceased AU582757B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT48491/84 1984-07-03
IT48491/84A IT1177863B (it) 1984-07-03 1984-07-03 Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche

Publications (2)

Publication Number Publication Date
AU4420785A AU4420785A (en) 1986-01-02
AU582757B2 true AU582757B2 (en) 1989-04-13

Family

ID=11266882

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44207/85A Ceased AU582757B2 (en) 1984-07-03 1985-06-26 A gangliosides mixture, useful as a therapeutical tool for eliminating painful effects of peripheral neuropathies

Country Status (11)

Country Link
US (1) US4707469A (OSRAM)
EP (1) EP0183572B1 (OSRAM)
JP (1) JPS6130521A (OSRAM)
AT (1) ATE78171T1 (OSRAM)
AU (1) AU582757B2 (OSRAM)
BE (1) BE902753A (OSRAM)
DE (1) DE3523021A1 (OSRAM)
GR (1) GR851572B (OSRAM)
IT (1) IT1177863B (OSRAM)
LU (1) LU85974A1 (OSRAM)
ZA (1) ZA854865B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6168418A (ja) * 1984-09-11 1986-04-08 Kanto Ishi Pharma Co Ltd 去痰薬
AU594468B2 (en) * 1986-05-12 1990-03-08 Mect Corporation Sialosylcholesterol, process for its preparation, and drug for treating diseases of nervous system
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
US4937232A (en) * 1986-09-15 1990-06-26 Duke University Inhibition of protein kinase C by long-chain bases
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IN171530B (OSRAM) * 1989-11-17 1992-11-07 Fidia Spa
IT1249034B (it) * 1990-06-29 1995-02-11 Fidia Spa Impiego del monosialoganglioside gm1 e del suo derivato estere interno per impedire l'instaurarsi della tolleranza nell'uomo all'effetto analgesico della morfina e analoghi
EP0539380B1 (en) * 1991-05-16 2000-08-09 FIDIA S.p.A. Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
GB2388777A (en) * 2000-12-08 2003-11-26 Childrens Memorial Hospital Compositions containing gangliosides for use in the treatment of skin disorders
JP2005527467A (ja) 2001-08-29 2005-09-15 ネオーズ テクノロジーズ， インコーポレイテッド 新規な合成ガングリオシド誘導体およびその組成物
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
WO2004080960A2 (en) 2003-03-06 2004-09-23 Neose Technologies Inc. Methods and compositions for the enzymatic synthesis of gangliosides
US20050112183A1 (en) * 2003-11-25 2005-05-26 Galer Bradley S. Compositions and methods for treating neuropathic sensory loss
US20120035120A1 (en) 2009-03-25 2012-02-09 Seneb Biosciences, Inc. Glycolipids as treatment for disease
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US10617701B2 (en) 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
CN111407768A (zh) * 2020-05-15 2020-07-14 内蒙古自治区中医药研究所 一类组合物在神经损伤保护领域的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0145209A2 (en) * 1983-11-08 1985-06-19 FIDIA S.p.A. A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
EP0167449A2 (en) * 1984-07-03 1986-01-08 FIDIA S.p.A. New ganglioside derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1046051B (it) * 1975-08-13 1980-06-30 Fidia Spa Nuova applicazione terapeutica dei gangliosidi e procedimento per la loro estrazione

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0145209A2 (en) * 1983-11-08 1985-06-19 FIDIA S.p.A. A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
EP0167449A2 (en) * 1984-07-03 1986-01-08 FIDIA S.p.A. New ganglioside derivatives

Also Published As

Publication number Publication date
IT1177863B (it) 1987-08-26
EP0183572B1 (en) 1992-07-15
AU4420785A (en) 1986-01-02
EP0183572A3 (en) 1987-07-22
DE3523021A1 (de) 1986-01-09
IT8448491A1 (it) 1986-01-03
GR851572B (OSRAM) 1985-11-25
IT8448491A0 (it) 1984-07-03
ATE78171T1 (de) 1992-08-15
JPS6130521A (ja) 1986-02-12
ZA854865B (en) 1987-09-30
BE902753A (nl) 1985-12-30
EP0183572A2 (en) 1986-06-04
LU85974A1 (fr) 1986-01-22
US4707469A (en) 1987-11-17

Similar Documents

Publication Publication Date Title
AU4420785A (en) A gangliosides mixture, useful as a therapeutical tool for eliminating painful effects of peripheral neuropathies
AU597635B2 (en) Treatment of diseases caused by retroviruses
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
PL252614A1 (en) Method of producing therapeutically active constant unit dose
MY132705A (en) Novel compounds with analgesic effect
AU6747887A (en) Treatment of skin disorders
GB2162747A (en) Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
ZA855916B (en) Treatment of skin disorders
EP0151989A3 (en) Means for the treatment of cardiac diseases
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
AU6857887A (en) Therapeutic agent
HUT38897A (en) Process for producing pharmaceutically active substituted benzamides and pharmaceutical compositions containing them as active agents
ZA898605B (en) Compositions for topical treatment of skin diseases
AU6337886A (en) Glutamine treatment of catabolic dysfunction
AU590783B2 (en) Therapeutic agent for treating hematopoietic diseases
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
AU5917390A (en) Pharmaceutical composition for topic use for the therapeutical treatment of capillary fragility
AU6216886A (en) Substituted 2-cyano-2-phenyl ethyl-amine
GB2163051A (en) Medicinal composition for the treatment or prevention of acne by topical application
AU591107B2 (en) Psoralene-based bath compositions for treatment of skin disorders
AU584120B2 (en) Topical treatment of skin inflammatory disorders
AU5259486A (en) Arylalkoxyphenyl-allylic alcohols as agents for the treatment of hypersensitive ailments
GR3004272T3 (OSRAM)
NZ271496A (en) Treating hiv; use of azaspirane compounds to manufacture medicaments
IL74317A0 (en) Substituted oxiranes,their preparation and their use for treatment of plants